Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Methotrexate		ESCA
Methyldopa tablets
Methylphenidate tablets	TA98 - Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents	ESCAs and additional advice in relation to age of patient and CCG
Mexiletine hydrochloride 100mg & 200mg capsules		Unlicensed. Use with local trust approval. Available from "Special order" manufacturers or specialist importing companies.
Mezavant XL
Midodrine		3rd line after non-pharmacological intervention, 2nd line after pharmacological therapy. Supported with an ESCA.
Minoxidil tablets
Mirtazapine orodispersible tablets		Palliative care team initiation
Mirtazapine tablets		Palliative care team initiation
Misoprostol		Specialist use only

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.